Medtronic plc June 15th Short Interest Update

Medtronic plc (NYSE:MDT), A rise of 4,225,625 shares or 33.5% was seen in the short interest of Medtronic plc. Even as the interest increased from 12,620,008 shares on May 31,2016 to 16,845,633 shares on June 15,2016, the days to cover came in at 3. The updated interest stood at 1.2% of the stocks floats. The stock has seen an average daily volume of 5,772,442 shares. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 24th after market close.

Medtronic plc (NYSE:MDT): The stock opened at $83.77 on Friday but the bulls could not build on the opening and the stock topped out at $84.81 for the day. The stock traded down to $83.05 during the day, due to lack of any buying support eventually closed down at $83.26 with a loss of -2.93% for the day. The stock had closed at $85.77 on the previous day. The total traded volume was 7,485,180 shares.

The company shares have rallied 13.59% from its 1 Year high price. On Jun 13, 2016, the shares registered one year high at $86.31 and the one year low was seen on Aug 24, 2015. The 50-Day Moving Average price is $82.58 and the 200 Day Moving Average price is recorded at $77.87.

Medtronic plc (NYSE:MDT) has tumbled 1.05% during the past week, however, the bigger picture is still very bullish; the stocks have advanced and posted positive gains of 1.92% in the last four weeks. In the past week, the company has outperformed the S&P 500 by 0.6% and the outperformance has advanced to 5.01% for the last 4 weeks period.

Medtronic plc (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic, Inc. is a subsidiary of the Company.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *